New Oral Antibiotic Shows Promise for Treating MRSA-Related Skin Infections

According to a new study published in the Journal of the American Medical Association, a new oral antibiotic may effectively treat MRSA-related skin infections more quickly than the only oral drug currently approved for treating these infections.

The new oral antibiotic is tedizolid phosphate, which was determined to be "clinically noninferior" to linezolid, the only drug currently approved for treating skin structure infections, or SSIs, caused by MRSA. These infections can be deadly.

The researchers also noted that there have been outbreaks of linezolid-resistant strains of MRSA.

To learn more, click here.